Literature DB >> 33588810

Dedifferentiated chondrsarcoma: a clinicopathologic analysis of 25 cases.

Lei Cao1, Yuan Wu2, Shu-Man Han1, Tao Sun1, Bao-Hai Yu1, Feng Gao1, Wen-Juan Wu3, Bu-Lang Gao1.   

Abstract

BACKGROUND: To investigate the clinical, imaging and pathological features of dedifferentiated chondrosarcoma for better diagnosis.
METHODS: Patients who had been confirmed to have dedifferentiated chondrosarcoma were enrolled in this study and analyzed in the clinical, imaging and pathological data.
RESULTS: Twenty-five patients had pathologically confirmed dedifferentiated chondrosarcoma including 15 males and 10 females with an age range of 24-74 (median 58, interquartile range 49-65). Ten patients had the tumor at the femur, four at the ilium, two at the humerus, two at the tibia, two at cotyle, and one at each of the following locations: scapula, sacrum, rib, pubic branch, and calcaneus. Twenty-one patients had local pain and a soft tissue mass while the other four patients had only local pain without a soft tissue mass. Four patients had pathological fractures. Imaging showed extensive bone destruction with calcification inside the lesion and possible pathological fractures. On gross observation of the specimen, the chondrosarcoma components were usually located inside the bone, and the dedifferentiated sarcoma components were mainly located outside the bone. Microscopy showed the dedifferentiated tumor had two components: well-differentiated chondrosarcoma and poorly differentiated non-chondral sarcoma including malignant fibrous histiocytoma in eleven cases, osteosarcoma in ten cases, fibrosarcoma in two, liomyosarcoma in one, and lipoblastoma in the remaining one.. Followed up from 3 moths to 60 months (mean 15.6), eight patients died with a survival time of 10-23 months (mean 16), and the other 17 patients survived with the survival duration from three to 60 months (15).
CONCLUSION: Dedifferentiated chondrosarcoma is a fatal disease with multiple components, and most of the cases have dual morphological and imaging features of chondrosarcoma and non-chondrosarcoma. The imaging presentations are primarily of common central chondrosarcoma, combined with cortical destruction, soft tissue mass, and pathological fractures.

Entities:  

Keywords:  Dedifferentiated chondrosarcoma; Diagnosis; Imaging; Microscopy; Pathology

Mesh:

Year:  2021        PMID: 33588810      PMCID: PMC7885579          DOI: 10.1186/s12891-021-04053-7

Source DB:  PubMed          Journal:  BMC Musculoskelet Disord        ISSN: 1471-2474            Impact factor:   2.362


  24 in total

1.  Dedifferentiated central chondrosarcoma.

Authors:  Eric L Staals; Patrizia Bacchini; Franco Bertoni
Journal:  Cancer       Date:  2006-06-15       Impact factor: 6.860

2.  Is dedifferentiated chondrosarcoma a 'de-differentiated' chondrosarcoma?

Authors:  T Aigner; K K Unni
Journal:  J Pathol       Date:  1999-12       Impact factor: 7.996

3.  Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1.

Authors:  Rieko Oyama; Fusako Kito; Mami Takahashi; Marimu Sakumoto; Kumiko Shiozawa; Zhiwei Qiao; Rei Noguchi; Takashi Kubo; Shunichi Toki; Fumihiko Nakatani; Akihiko Yoshida; Akira Kawai; Tadashi Kondo
Journal:  Hum Cell       Date:  2019-02-08       Impact factor: 4.174

4.  Case report 347. Dedifferentiated chondrosarcoma: grade 4 fibrosarcoma arising in grade 1 chondrosarcoma (femur).

Authors:  F J Frassica; K K Unni; F H Sim
Journal:  Skeletal Radiol       Date:  1986       Impact factor: 2.199

5.  Dedifferentiation of low-grade chondrosarcomas.

Authors:  D C Dahlin; J W Beabout
Journal:  Cancer       Date:  1971-08       Impact factor: 6.860

6.  Dedifferentiated chondrosarcoma. A report of the clinicopathological features and treatment of seventy-eight cases.

Authors:  F J Frassica; K K Unni; J W Beabout; F H Sim
Journal:  J Bone Joint Surg Am       Date:  1986-10       Impact factor: 5.284

7.  Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes.

Authors:  Ian D Dickey; Peter S Rose; Bruno Fuchs; Lester E Wold; Scott H Okuno; Franklin H Sim; Sean P Scully
Journal:  J Bone Joint Surg Am       Date:  2004-11       Impact factor: 5.284

Review 8.  Chondrosarcoma of the pelvis. A review of sixty-four cases.

Authors:  M E Pring; K L Weber; K K Unni; F H Sim
Journal:  J Bone Joint Surg Am       Date:  2001-11       Impact factor: 5.284

9.  Dedifferentiated chondrosarcoma.

Authors:  M Mercuri; P Picci; L Campanacci; E Rulli
Journal:  Skeletal Radiol       Date:  1995-08       Impact factor: 2.199

10.  Dedifferentiated chondrosarcoma of the pelvis: clinical outcomes and current treatment.

Authors:  Johnathan R Lex; Scott Evans; Jonathan D Stevenson; Michael Parry; Lee M Jeys; Robert J Grimer
Journal:  Clin Sarcoma Res       Date:  2018-12-14
View more
  1 in total

1.  Clinical features and treatment outcomes of dedifferentiated and grade 3 chondrosarcoma: A multi-institutional study.

Authors:  Eiji Kozawa; Yoshihiro Nishida; Akira Kawai; Keiko Hayakawa; Nokitaka Setsu; Hiroyuki Kawashima; Shintaro Iwata; Hiroyuki Tsuchiya; Satoshi Tsukushi; Satoshi Takenaka; Jungo Imanishi; Ichiro Baba; Akihito Nagano; Takeshi Morii; Toshiharu Shirai; Koki Shimizu; Hirotaka Kawano
Journal:  Cancer Sci       Date:  2022-05-18       Impact factor: 6.518

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.